Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: PTO Issues Initial Office Action on Tessera Patent
I'm ok if we plummet to $11 a share, down 50% as long as we can hold the $11. 
Share
New Message
Please login to post a reply